|
1
|
Donnelly RF, Singh TR, Garland MJ, et al:
Hydrogel-forming microneedle arrays for enhanced transdermal drug
delivery. Adv Funct Mater. 22:4879–4890. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bennet D and Kim S: A transdermal delivery
system to enhance quercetin nanoparticle permeability. J Biomater
Sci Polym Ed. 24:185–209. 2013.PubMed/NCBI
|
|
3
|
Ruan RQ, Wang SS, Wang CL, et al:
Transdermal delivery of human epidermal growth factor facilitated
by a peptide chaperon. Eur J Med Chem. 62:405–409. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo R, Du X, Zhang R, et al: Bioadhesive
film formed from a novel organic-inorganic hybrid gel for
transdermal drug delivery system. Eur J Pharm Biopharm. 79:574–583.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartosova L and Bajgar J: Transdermal drug
delivery in vitro using diffusion cells. Curr Med Chem.
19:4671–4677. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lane ME: Skin penetration enhancers. Int J
Pharm. 447:12–21. 2013. View Article : Google Scholar
|
|
7
|
Marren K: Dimethyl sulfoxide: an effective
penetration enhancer for topical administration of NSAIDs. Phys
Sportsmed. 39:75–82. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chinna Reddy P, Chaitanya KS and
Madhusudan Rao Y: A review on bioadhesive buccal drug delivery
systems: current status of formulation and evaluation methods.
Daru. 19:385–403. 2011.PubMed/NCBI
|
|
9
|
Purdon CH, Azzi CG, Zhang J, et al:
Penetration enhancement of transdermal delivery - current
permutations and limitations. Crit Rev Ther Drug Carrier Syst.
21:97–132. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kanikkannan N, Kandimalla K, Lamba SS, et
al: Structure-activity relationship of chemical penetration
enhancers in transdermal drug delivery. Curr Med Chem. 7:593–608.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang H, Zhong CY, Wu JF, et al:
Enhancement of TAT cell membrane penetration efficiency by dimethyl
sulphoxide. J Control Release. 143:64–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gurtovenko AA and Anwar J: Modulating the
structure and properties of cell membranes: the molecular mechanism
of action of dimethyl sulfoxide. J Phys Chem B. 111:10453–10460.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen X, Zhang Y, Liu C, Zhang Y, Zhou X,
Zhou T, Mao Y, Kan B, Wei YQ and Li J: Retinoic acid and dimethyl
sulfoxide promote efficient delivery of transgenes to mouse skin by
topically transdermal penetration. Drug Deliv. 17:385–390. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Usoltsev NA and Dhamee MS: Perioperative
retinoic acid syndrome in a patient with acute promyelocytic
leukemia. J Clin Anesth. 24:315–317. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bajor M and Kaczmarek L: Proteolytic
remodeling of the synaptic cell adhesion molecules (CAMs) by
metzincins in synaptic plasticity. Neurochem Res. 38:1113–1121.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yadav S, Wickett RR, Pinto NG, et al:
Comparative thermodynamic and spectroscopic properties of water
interaction with human stratum corneum. Skin Res Technol.
15:172–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abla N, Naik A, Guy RH, et al:
Contributions of electromigration and electroosmosis to peptide
iontophoresis across intact and impaired skin. J Control Release.
108:319–330. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
do Couto SG, de Oliveira MS and Alonso A:
Dynamics of proteins and lipids in the stratum corneum: effects of
percutaneous permeation enhancers. Biophys Chem. 116:23–31.
2005.PubMed/NCBI
|
|
19
|
Chen M, Liu X and Fahr A: Skin delivery of
ferulic acid from different vesicular systems. J Biomed
Nanotechnol. 6:577–585. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Eleftheriadis T, Pissas G, Liakopoulos V,
et al: Toll-like receptors and their role in renal pathologies.
Inflamm Allergy Drug Targets. 11:464–477. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McIsaac SM, Stadnyk AW and Lin TJ:
Toll-like receptors in the host defense against Pseudomonas
aeruginosa respiratory infection and cystic fibrosis. J Leukoc
Biol. 92:977–985. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Wang X, Zhang F, et al: Toll-like
receptors as therapeutic targets for autoimmune connective tissue
diseases. Pharmacol Ther. 138:441–451. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aderem A and Ulevitch RJ: Toll-like
receptors in the induction of the innate immune response. Nature.
406:782–787. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Michaud JP, Richard KL and Rivest S:
Hematopoietic MyD88-adaptor protein acts as a natural defense
mechanism for cognitive deficits in Alzheimer’s disease. Stem Cell
Rev. 8:898–904. 2012.PubMed/NCBI
|
|
25
|
Hou B, Benson A, Kuzmich L, et al:
Critical coordination of innate immune defense against
Toxoplasma gondii by dendritic cells responding via their
Toll-like receptors. Proc Natl Acad Sci USA. 108:278–283.
2011.PubMed/NCBI
|
|
26
|
Herath TD, Darveau RP, Seneviratne CJ, et
al: Tetra- and penta-acylated lipid A structures of
Porphyromonas gingivalis LPS differentially activate
TLR4-mediated NF-κB signal transduction cascade and
immuno-inflammatory response in human gingival fibroblasts. PLoS
One. 8:e584962013.PubMed/NCBI
|
|
27
|
Yáñez A, Hassanzadeh-Kiabi N, Ng MY, et
al: Detection of a TLR2 agonist by hematopoietic stem and
progenitor cells (HSPCs) impacts the function of the macrophages
they produce. Eur J Immunol. 43:2114–2125. 2013.PubMed/NCBI
|
|
28
|
Sorgi CA, Rose S, Court N, et al: GM-CSF
priming drives bone marrow-derived macrophages to a
pro-inflammatory pattern and downmodulates PGE2 in response to TLR2
ligands. PLoS One. 7:e405232012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kuo IH, Carpenter-Mendini A, Yoshida T, et
al: Activation of epidermal toll-like receptor 2 enhances tight
junction function: implications for atopic dermatitis and skin
barrier repair. J Invest Dermatol. 133:988–998. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Campbell L, Williams H, Crompton RA, et
al: Nod2 deficiency impairs inflammatory and epithelial aspects of
the cutaneous wound-healing response. J Pathol. 229:121–131. 2013.
View Article : Google Scholar : PubMed/NCBI
|
